NutraLife BioSciences, Inc.
NLBS
OTC PK
| 09/30/2022 | 06/30/2022 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Net Income | -4.95M | -4.46M | -5.37M | -6.79M | -5.98M |
| Total Depreciation and Amortization | 421.60K | 398.40K | 371.20K | 326.40K | 329.40K |
| Total Amortization of Deferred Charges | 341.80K | 410.90K | 474.10K | 438.20K | 346.40K |
| Total Other Non-Cash Items | 2.35M | 1.90M | 2.70M | 4.20M | 3.69M |
| Change in Net Operating Assets | 1.17M | 1.20M | 1.24M | 1.34M | 279.80K |
| Cash from Operations | -669.50K | -559.30K | -584.50K | -487.30K | -1.34M |
| Capital Expenditure | -3.20K | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.90M | -1.40M | -1.40M | -675.00K | -- |
| Cash from Investing | -1.90M | -1.40M | -1.40M | -675.00K | -- |
| Total Debt Issued | 661.70K | 1.84M | 575.10K | 968.40K | 1.09M |
| Total Debt Repaid | -257.70K | -110.30K | -63.40K | -18.90K | -19.80K |
| Issuance of Common Stock | 110.00K | 265.00K | 458.00K | 348.00K | 348.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 2.36M | 0.00 | 975.00K | -- | 0.00 |
| Cash from Financing | 2.87M | 2.00M | 1.94M | 1.30M | 1.41M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 301.20K | 39.10K | -39.90K | 135.00K | 75.90K |
